About 62% a year, can a noticeable surgery continue growing up?

Spread the love

The role of the Roman surgeon Cannot be identified (Nasadak ISRG) It has been increasing recently. The first look at the 2024 fourth quarter of sales indicates that the business is on the right path.

Intestinal Services and the future of the future is amazing, and investors have noticed. On January 22, 2025 well-based medical technologies of medical technologies in the 7 months of medical technology in January 1225 have increased 62 percent of medical technology.

Is it still a good time to buy an intectic channel or is already far away? Below, I will consider some of the reasons that the stock grew, if it is time to buy some stocks.

In January 15, Intecting Sergeral has made 2024 primary results from the fourth quarter. His Recean Surgical robot system represents a major translation to hospitals, but where they are willing to do. Hospitals around the world have placed 493 Dai Vinci surgeons in the third quarter.

The new da Vinci 5 System extends 2 million and 2.5 million. This is greatly greater than the past repetitions, but it does not prevent hospitals from purchasing or renting the new systems.

Aware of surgical surgeon can have valuable importance from the competition. unlike StykerInfuxcopic tower products, Da Vinci to a tower of the 5 victorial and other features of other features.

Known surgery is not only to save a simple generation of surgery but also to sell tools that must be replaced by each system. The fourth quarter of equipment and flexive sales raises 23 percent higher than $ 1.4 billion and 58.5% of the total income.

In addition to 2024 fourth quarter, antichrist instructions for 2025 for 2025. Administration expects the process of the process from 13 percent to 16% higher than 13 percent.

The only company that sells the equipment and accessories, which hospitals need to use their daughter 5 robots, which requires a lot of inflation power. The sale of equipment and spying items is greater than just a few percentage points. In other words, the company’s largest flow of the company may increase more than 13% in 2025.

In addition to the integrated King, the new Daj Vinci 5 System 5 systems may be influenced by the energy feedback that can be drawn to the powers on the tissues.

Medical-technology huge Johnson and Johnson (NYSE: JNJ) It’s spreading a new robotic surgery, but it’s a long way behind the market leader. J & j last November Last No November in Otta Robotic surgery began to register with a clinical test.

By Rinch 5 Scenting Investigation in Robot, the company’s stocks are being trained by the prime value of the company. Investors paid maximum price 77 Last income for the future Be protected for stock.

Intectict Sergically is racking by the blood of nose because investors are thinking that J & j will take the lead in the next generation. It is a good philosophers who are expelled by a new robot and use the workers to use the workers.

While there are good reasons to estimate intitious Services for many years, individual investors must recognize the risks related to sack. In the following number of years, the Administration issued ahead of the high expectations of the Wolve Street, the stock of stock may fail. It’s better to look at this stock for now.

Have you ever felt that they had escaped the boat by purchasing very expedited stocks? Then they want to hear it.

Occasionally, our professional analysts team is a “Double down” collection Advice for companies who think that they are appear. Now is the time for time to buy before it expires if you are worried about investment. And the numbers talk for themselves:

Nivia If we double-double investing do $ 1,000 You will have 381,355! *
Apple In 2008, if we invest $ 1,000, You will have 42,390! *
Netouth If we doubled in 2004, if you invest $ 1,000 You will have 514,479! *

Now, I’m giving us a “Double DOWN” Alerts for three amazing companies, and may not be such a chance soon.

Learn more “

* Stock Advisor will return since January 21, 2025

CORY RENAER There is no place in the stocks mentioned. Motley fool has spaces and recommends a known surgery. MOTLEY FOOLSSONSSON and JERER. Motley Fool Positioning Policy.

About 62% a year, can a noticeable surgery continue growing up? The Motley fool is the first published.